Delcath Systems, Inc. (DCTH)
USD 10.96
(-8.21%)
USD 10.96
(-8.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 22.83 Million USD | -3.73% |
| 2022 | 23.72 Million USD | 12.04% |
| 2021 | 21.17 Million USD | 68.61% |
| 2020 | 12.55 Million USD | -38.95% |
| 2019 | 20.56 Million USD | -5.57% |
| 2018 | 21.78 Million USD | 165.36% |
| 2017 | 8.2 Million USD | -77.65% |
| 2016 | 36.72 Million USD | 414.99% |
| 2015 | 7.13 Million USD | 26.93% |
| 2014 | 5.61 Million USD | -19.71% |
| 2013 | 6.99 Million USD | -33.13% |
| 2012 | 10.46 Million USD | 14.53% |
| 2011 | 9.13 Million USD | -57.5% |
| 2010 | 21.49 Million USD | 64.75% |
| 2009 | 13.04 Million USD | 1032.89% |
| 2008 | 1.15 Million USD | -31.33% |
| 2007 | 1.67 Million USD | 150.2% |
| 2006 | 670.36 Thousand USD | 103.1% |
| 2005 | 330.07 Thousand USD | -41.54% |
| 2004 | 564.62 Thousand USD | 117.0% |
| 2003 | 260.2 Thousand USD | 48.54% |
| 2002 | 175.17 Thousand USD | -0.52% |
| 2001 | 176.08 Thousand USD | -82.89% |
| 2000 | 1.02 Million USD | 835.38% |
| 1999 | 110 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 29.72 Million USD | 38.37% |
| 2024 Q1 | 21.47 Million USD | -5.94% |
| 2023 Q3 | 22.85 Million USD | 7.35% |
| 2023 Q1 | 43.67 Million USD | 84.12% |
| 2023 Q2 | 21.29 Million USD | -51.25% |
| 2023 Q4 | 22.83 Million USD | -0.1% |
| 2023 FY | 22.83 Million USD | -3.73% |
| 2022 Q4 | 23.72 Million USD | -6.87% |
| 2022 Q3 | 25.47 Million USD | 6.52% |
| 2022 FY | 23.72 Million USD | 12.04% |
| 2022 Q2 | 23.91 Million USD | 8.24% |
| 2022 Q1 | 22.09 Million USD | 4.35% |
| 2021 FY | 21.17 Million USD | 68.61% |
| 2021 Q1 | 12.3 Million USD | -1.97% |
| 2021 Q2 | 9.75 Million USD | -20.72% |
| 2021 Q3 | 22.69 Million USD | 132.62% |
| 2021 Q4 | 21.17 Million USD | -6.73% |
| 2020 Q4 | 12.55 Million USD | -5.51% |
| 2020 Q1 | 17.78 Million USD | -13.55% |
| 2020 Q2 | 12.74 Million USD | -28.35% |
| 2020 Q3 | 13.28 Million USD | 4.3% |
| 2020 FY | 12.55 Million USD | -38.95% |
| 2019 FY | 20.56 Million USD | -5.57% |
| 2019 Q4 | 20.56 Million USD | -45.47% |
| 2019 Q3 | 37.72 Million USD | 6.66% |
| 2019 Q1 | 29.94 Million USD | 37.45% |
| 2019 Q2 | 35.36 Million USD | 18.12% |
| 2018 Q4 | 21.78 Million USD | 23.09% |
| 2018 FY | 21.78 Million USD | 165.36% |
| 2018 Q1 | 12.62 Million USD | 53.73% |
| 2018 Q2 | 18.56 Million USD | 47.09% |
| 2018 Q3 | 17.69 Million USD | -4.67% |
| 2017 Q1 | 31.62 Million USD | -13.9% |
| 2017 FY | 8.2 Million USD | -77.65% |
| 2017 Q4 | 8.2 Million USD | -49.75% |
| 2017 Q3 | 16.33 Million USD | -7.89% |
| 2017 Q2 | 17.73 Million USD | -43.92% |
| 2016 Q1 | 4.66 Million USD | -34.53% |
| 2016 Q3 | 32.49 Million USD | -9.63% |
| 2016 Q4 | 36.72 Million USD | 13.03% |
| 2016 FY | 36.72 Million USD | 414.99% |
| 2016 Q2 | 35.95 Million USD | 670.14% |
| 2015 Q4 | 7.13 Million USD | 17.85% |
| 2015 Q2 | 4.27 Million USD | -18.14% |
| 2015 FY | 7.13 Million USD | 26.93% |
| 2015 Q1 | 5.22 Million USD | -6.99% |
| 2015 Q3 | 6.05 Million USD | 41.47% |
| 2014 Q1 | 6.43 Million USD | -8.06% |
| 2014 FY | 5.61 Million USD | -19.71% |
| 2014 Q2 | 6.14 Million USD | -4.43% |
| 2014 Q3 | 6.18 Million USD | 0.55% |
| 2014 Q4 | 5.61 Million USD | -9.12% |
| 2013 Q3 | 5.41 Million USD | 1.29% |
| 2013 Q2 | 5.35 Million USD | -51.73% |
| 2013 FY | 6.99 Million USD | -33.13% |
| 2013 Q1 | 11.08 Million USD | 5.91% |
| 2013 Q4 | 6.99 Million USD | 29.14% |
| 2012 Q2 | 13.62 Million USD | 53.87% |
| 2012 FY | 10.46 Million USD | 14.53% |
| 2012 Q1 | 8.85 Million USD | -3.08% |
| 2012 Q3 | 10.06 Million USD | -26.12% |
| 2012 Q4 | 10.46 Million USD | 3.95% |
| 2011 Q4 | 9.13 Million USD | 7.8% |
| 2011 Q1 | 14.62 Million USD | -31.98% |
| 2011 FY | 9.13 Million USD | -57.5% |
| 2011 Q2 | 11.32 Million USD | -22.58% |
| 2011 Q3 | 8.47 Million USD | -25.13% |
| 2010 Q3 | 14.92 Million USD | 15.92% |
| 2010 FY | 21.49 Million USD | 64.75% |
| 2010 Q4 | 21.49 Million USD | 44.0% |
| 2010 Q2 | 12.87 Million USD | -39.99% |
| 2010 Q1 | 21.46 Million USD | 64.47% |
| 2009 Q2 | 7.44 Million USD | 509.0% |
| 2009 Q3 | 11.7 Million USD | 57.17% |
| 2009 FY | 13.04 Million USD | 1032.89% |
| 2009 Q4 | 13.04 Million USD | 11.45% |
| 2009 Q1 | 1.22 Million USD | 6.2% |
| 2008 Q4 | 1.15 Million USD | 13.81% |
| 2008 Q3 | 1.01 Million USD | -53.6% |
| 2008 Q2 | 2.18 Million USD | 52.14% |
| 2008 Q1 | 1.43 Million USD | -14.52% |
| 2008 FY | 1.15 Million USD | -31.33% |
| 2007 Q1 | 275.94 Thousand USD | -58.84% |
| 2007 Q3 | 4.45 Million USD | 3399.69% |
| 2007 Q2 | 127.36 Thousand USD | -53.84% |
| 2007 FY | 1.67 Million USD | 150.2% |
| 2007 Q4 | 1.67 Million USD | -62.37% |
| 2006 Q4 | 670.36 Thousand USD | -62.24% |
| 2006 Q3 | 1.77 Million USD | 99.7% |
| 2006 Q2 | 888.97 Thousand USD | 346.51% |
| 2006 Q1 | 199.09 Thousand USD | -39.68% |
| 2006 FY | 670.36 Thousand USD | 103.1% |
| 2005 Q2 | 430.32 Thousand USD | -30.84% |
| 2005 FY | 330.07 Thousand USD | -41.54% |
| 2005 Q4 | 330.07 Thousand USD | 48.53% |
| 2005 Q3 | 222.21 Thousand USD | -48.36% |
| 2005 Q1 | 622.22 Thousand USD | 10.2% |
| 2004 Q1 | 674.23 Thousand USD | 159.12% |
| 2004 Q2 | 524.4 Thousand USD | -22.22% |
| 2004 Q3 | 513.34 Thousand USD | -2.11% |
| 2004 Q4 | 564.62 Thousand USD | 9.99% |
| 2004 FY | 564.62 Thousand USD | 117.0% |
| 2003 FY | 260.2 Thousand USD | 48.54% |
| 2003 Q4 | 260.2 Thousand USD | -22.77% |
| 2003 Q3 | 336.91 Thousand USD | -20.34% |
| 2003 Q2 | 422.92 Thousand USD | 41.42% |
| 2003 Q1 | 299.05 Thousand USD | 70.72% |
| 2002 Q1 | 232.8 Thousand USD | 32.22% |
| 2002 Q2 | 147.4 Thousand USD | -36.69% |
| 2002 FY | 175.17 Thousand USD | -0.52% |
| 2002 Q3 | 248.97 Thousand USD | 68.91% |
| 2002 Q4 | 175.17 Thousand USD | -29.64% |
| 2001 Q3 | 133.95 Thousand USD | -32.83% |
| 2001 Q4 | 176.08 Thousand USD | 31.45% |
| 2001 FY | 176.08 Thousand USD | -82.89% |
| 2001 Q1 | 453.99 Thousand USD | -55.88% |
| 2001 Q2 | 199.42 Thousand USD | -56.07% |
| 2000 FY | 1.02 Million USD | 835.38% |
| 2000 Q4 | 1.02 Million USD | 73.3% |
| 2000 Q3 | 593.71 Thousand USD | 182.72% |
| 2000 Q2 | 210 Thousand USD | 0.0% |
| 1999 FY | 110 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accuray Incorporated | 423.54 Million USD | 94.608% |
| Envoy Medical, Inc. | 9.4 Million USD | -142.884% |
| Xylo Technologies Ltd. | 31.46 Million USD | 27.415% |